Insulin-Like Growth Factor-II Is Increased in Systemic Sclerosis-Associated Pulmonary Fibrosis and Contributes to the Fibrotic Process via Jun N-Terminal Kinase- and Phosphatidylinositol-3 Kinase-Dependent Pathways

類似資料

• Lung tissues in systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension
  著者:: Hsu, Eileen, 等
  出版事項: (2011)
• An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model
  著者:: Nishimoto, Tetsuya, 等
  出版事項: (2015)
• Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
  著者:: Garrett, Sara M., 等
  出版事項: (2019)
• Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis
  著者:: Nguyen, Xinh-Xinh, 等
  出版事項: (2021)
• c-Jun N-Terminal Kinase 1 Is Required for the Development of Pulmonary Fibrosis
  著者:: Alcorn, John F., 等
  出版事項: (2009)